Hazel Burke

Sydney, NSW, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Prospective tumour mutation burden and neoantigen profiling predicts immunotherapy response in metastatic melanoma.

Prospective tumour mutation burden and neoantigen profiling predicts immunotherapy response in metastatic melanoma.

Journal: NPJ precision oncology
Published: July 21, 2025

Prognostic Significance of Incipient Ulceration in Primary Cutaneous Melanoma.

Prognostic Significance of Incipient Ulceration in Primary Cutaneous Melanoma.

Journal: JAMA dermatology
Published: November 01, 2023

Lentigo maligna and lentigo maligna melanoma in young patients in Australian tertiary centres.

Lentigo maligna and lentigo maligna melanoma in young patients in Australian tertiary centres.

Journal: Clinical and experimental dermatology
Published: March 05, 2023

InterMEL: An international biorepository and clinical database to uncover predictors of survival in early-stage melanoma.

InterMEL: An international biorepository and clinical database to uncover predictors of survival in early-stage melanoma.

Journal: PloS one
Published: May 12, 2022

Clinicopathological characteristics of new primary melanomas in patients receiving immune checkpoint inhibitor therapy for metastatic melanoma.

Clinicopathological characteristics of new primary melanomas in patients receiving immune checkpoint inhibitor therapy for metastatic melanoma.

Journal: The Australasian journal of dermatology
Published: January 25, 2021

Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets.

Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets.

Journal: Nature communications
Published: December 06, 2018

Whole-genome landscapes of major melanoma subtypes.

Whole-genome landscapes of major melanoma subtypes.

Journal: Nature
Published: November 22, 2015

Tumor PD-L1 expression, immune cell correlates and PD-1+ lymphocytes in sentinel lymph node melanoma metastases.

Tumor PD-L1 expression, immune cell correlates and PD-1+ lymphocytes in sentinel lymph node melanoma metastases.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: May 24, 2015
Showing 1-8 of 8

Last Updated: 09/26/2026